Clinical trial
Gut Microbiota Modulation With Synbiotics as Secondary Prevention After Acute Coronary Syndrome: A Randomized-Controlled Trial Pilot Study
NCT07411287 is registered in ClinicalTrials.gov with Centre Hospitalier de Bienne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gut Microbiota Modulation With Synbiotics as Secondary Prevention After Acute Coronary Syndrome: A Randomized-Controlled Trial Pilot Study
- Lead sponsor
- Centre Hospitalier de Bienne
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 1, 2026
- Completion date
- May 31, 2028
- Enrollment
- 80 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
atheroscleroses, coronary, microbiota